Davidson Investment Advisors’s AbbVie ABBV Stock Holding History

Davidson Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$850K	Sell	3,377 -100	-3%	-$21.5K	0.03%	94
2026 Q1	$756K	Sell	3,477 -50	-1%	-$11.1K	0.03%	97
2025 Q4	$806K	Buy	3,527 +600	+20%	+$137K	0.03%	98
2025 Q3	$678K	Buy	2,927 +58	+2%	+$11.8K	0.03%	98
2025 Q2	$533K	Hold	2,869	–	–	0.02%	99
2025 Q1	$601K	Hold	2,869	–	–	0.03%	94
2024 Q4	$510K	Sell	2,869 -1	-0%	-$184	0.02%	95
2024 Q3	$567K	Hold	2,870	–	–	0.03%	91
2024 Q2	$492K	Hold	2,870	–	–	0.03%	93
2024 Q1	$523K	Sell	2,870 -225	-7%	-$38.8K	0.03%	96
2023 Q4	$480K	Hold	3,095	–	–	0.03%	92
2023 Q3	$461K	Hold	3,095	–	–	0.03%	97
2023 Q2	$417K	Hold	3,095	–	–	0.03%	95
2023 Q1	$493K	Sell	3,095 -682	-18%	-$104K	0.03%	94
2022 Q4	$610K	Sell	3,777 -433	-10%	-$66.4K	0.05%	82
2022 Q3	$565K	Sell	4,210 -100	-2%	-$14.3K	0.05%	83
2022 Q2	$660K	Sell	4,310 -145	-3%	-$22.2K	0.06%	78
2022 Q1	$722K	Buy	4,455 +60	+1%	+$8.72K	0.05%	78
2021 Q4	$595K	Sell	4,395 -1,260	-22%	-$149K	0.04%	85
2021 Q3	$610K	Sell	5,655 -1,937	-26%	-$221K	0.05%	83
2021 Q2	$855K	Buy	7,592 +25	+0.3%	+$2.82K	0.07%	77
2021 Q1	$819K	Buy	7,567 +2,125	+39%	+$227K	0.07%	74
2020 Q4	$583K	Sell	5,442 -113	-2%	-$10.9K	0.05%	75
2020 Q3	$487K	Hold	5,555	–	–	0.05%	76
2020 Q2	$545K	Hold	5,555	–	–	0.06%	76
2020 Q1	$423K	Sell	5,555 -50	-0.9%	-$4.26K	0.05%	75
2019 Q4	$496K	Sell	5,605 -75	-1%	-$6.23K	0.05%	83
2019 Q3	$430K	Sell	5,680 -137	-2%	-$9.39K	0.04%	87
2019 Q2	$423K	Sell	5,817 -150	-3%	-$11.8K	0.04%	86
2019 Q1	$481K	Sell	5,967 -720	-11%	-$58.9K	0.05%	82
2018 Q4	$616K	Sell	6,687 -237	-3%	-$20.8K	0.07%	79
2018 Q3	$655K	Sell	6,924 -340	-5%	-$32.2K	0.07%	77
2018 Q2	$673K	Buy	7,264 +319	+5%	+$31.2K	0.07%	78
2018 Q1	$657K	Sell	6,945 -3,728	-35%	-$410K	0.07%	80
2017 Q4	$1.03M	Buy	10,673 +836	+8%	+$78.8K	0.11%	77
2017 Q3	$874K	Buy	9,837 +92	+0.9%	+$7K	0.09%	75
2017 Q2	$706K	Sell	9,745 -1,250	-11%	-$84K	0.1%	76
2017 Q1	$715K	Sell	10,995 -125	-1%	-$7.86K	0.09%	80
2016 Q4	$695K	Buy	11,120 +358	+3%	+$21.9K	0.1%	80
2016 Q3	$678K	Buy	10,762 +200	+2%	+$12.9K	0.1%	79
2016 Q2	$653K	Hold	10,562	–	–	0.11%	80
2016 Q1	$602K	Buy	10,562 +750	+8%	+$41.8K	0.1%	89
2015 Q4	$581K	Buy	9,812 +4,222	+76%	+$243K	0.1%	119
2015 Q3	$303K	Sell	5,590 -1,107	-17%	-$72.1K	0.05%	122
2015 Q2	$449K	Buy	6,697 +1,250	+23%	+$81.6K	0.07%	120
2015 Q1	$318K	Buy	5,447 +500	+10%	+$30.2K	0.05%	123
2014 Q4	$323K	Sell	4,947 -4,947	-50%	-$312K	0.05%	121
2014 Q3	$506K	Buy	9,894 +4,947	+100%	+$275K	0.04%	131
2014 Q2	$279K	Hold	4,947	–	–	0.04%	124
2014 Q1	$254K	Hold	4,947	–	–	0.04%	118
2013 Q4	$261K	Hold	4,947	–	–	0.04%	116
2013 Q3	$221K	Sell	4,947 -100	-2%	-$4.43K	0.04%	115
2013 Q2	$208K	Buy	+5,047	New	+$221K	0.03%	113

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Davidson Investment Advisors's ABBV Position: Q2 2026 in Review

Davidson Investment Advisors reduced its AbbVie (ABBV) stake by 2.9% in Q2 2026, selling an estimated $21.5K and leaving 3,377 shares worth $850K. The position accounts for 0.03% of the portfolio, ranked #94.

Davidson Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.03M in Q4 2017. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Davidson Investment Advisors held 3,377 shares of AbbVie worth $850K as of Q2 2026.
Davidson Investment Advisors sold 100 AbbVie shares in Q2 2026, an estimated $21.5K.
AbbVie made up 0.03% of Davidson Investment Advisors's portfolio in Q2 2026, its #94 holding.
Davidson Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Davidson Investment Advisors's AbbVie position peaked at $1.03M in Q4 2017.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Davidson Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.